PROFILE

SUZUKI Yusuke, M.D., Ph.D.


Department of Nephrology

Short Biography

1990
M.D. Juntendo University Faculty of Medicine
1990
Junior Resident of Internal Medicine, National Center for Global Health and Medicine
1992
Senior Resident of Nephrology, National Center for Global Health and Medicine
1993-
Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine
1997
Ph.D. Juntendo University Graduate School of Medicine
1999-2003
Postdoctoral Fellow, FJD, Madrid Autonoma University, Spain
2003
Assistant Professor, Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine
2005
Associate Professor, Juntendo University Graduate School of Medicine
2016.8-Present
Professor and Chairman, Department of Nephrology, Juntendo University Faculty of Medicine
 

Keywords

  • IgA nephropathy
  • Diabetic kidney disease (DKD)
  • Hypertension
  • Brain and cardio-renal connection
  • End-stage renal disease (ESRD) and renal replacement therapy (RRT)

Main Research Topics and Interests

  • Pathogenesis of IgA nephropathy and new diagnostic approach with pathogenesis-based biomarkers
  • Development of disease modifying therapy for IgA nephropathy
  • Uremic toxins-mediated vascular injury as a culprit for cardio-renal connection
  • Evaluation of tumor necrosis factor receptor as a biomarker for DKD
  • Roles of lipid mediators in kidney injury
  • Medical economics study on RRT

Publications (in English, ~2021/7)

  • Original Articles: 172
  • Review Articles: 31
  • Books: 3
  • h-Index: 39 (Scopus)
  • Sum of Times Cited: 5,784 (Scopus)

Recent Main Publications

  • Makita Y, Suzuki H, Suzuki Y. TLR9 activation induces aberrant IgA glycosylation via APRIL-and IL-6-mediated pathways in IgA nephropathy. Kidney Int. 97(2)340-349,2020
  • Gohda T, Kamei N, Koshida T, Kubota M, Tanaka K, Yamashita Y, Adachi E, Ichikawa S, Murakoshi M, Ueda S, Suzuki Y. Circulating kidney injury molecule-1 as a biomarker of renal parameters in diabetic kidney disease. J Diabetes Invest. 11(2):435-440,2020
  • Takahata A, Arai S, Hiramoto E, Kitada K, Kato R, Makita Y, Suzuki H, Nakata J, Araki K, Miyazaki T, Suzuki Y. Crucial role of AIM/CD5L in the development of glomerular inflammation in IgA. J Am Soc Nephrol., 2020 (in press)
  • More

Invited Lectures

  • Suzuki Y: “Pathogenesis of IgAN and its clinical application.” 55th ANZSN online Annual Scientific Meeting, Australia, Nov 28-Dec 2, 2020(on line)
  • Suzuki Y: “Novel therapies in IgA nephropathy.” 2020 Nephrology and Transplantation Update Course(55th ANZSN), Australia, Nov 28-29, 2020(on line)
  • Suzuki Y: “IgA nephropathy:Deciphering the relevant amidst the noise.” The ISN World Congress of Nephrology, Melbourne, Australia, Apr 12-15, 2019
  • Suzuki Y: “Diabetic Kidney Disease and its management”. Airlangga University, Surabaya, Indonesia, May 12, 2018
  • Suzuki Y: “IgA nephropathy: Novel biomarkers on Diagnosis and its clinical application”. Airlangga University, Surabaya, Indonesia, May 12, 2018
  • Suzuki Y: “IgA nephropathy: Novel biomarkers on Diagnosis and its clinical application”. Indonesia University, Jakarta, Indonesia, May 9, 2018
  • Suzuki Y: “Mucosal immune dysregulation and galactose-deficient IgA1 production in IgA nephropathy.” Korean Society of Nephropathy 2017. Seoul, Korea, May 18-21, 2017
  • Suzuki Y: CME course “IgA nephropathy”. Sister Renal Center Program, Hanoi Medical University, Viet Duc Hospital, Hanoi, Vietnam, Oct 28- Nov 3, 2017
  • Suzuki Y: “Tonsillar B cell activation via APRIL”. 14th International Symposium on IgA Nephropathy. Tours, France, Sep 15, 2016
  • Suzuki Y: “Models mimicking the pathophysiology of IgAN”. ISN NEXUS Symposium. Berlin, Germany, April 16, 2016

Other Specific Comments

  • Editorial board; Kidney International, Nephrology, Renal Replacement Therapy
  • Liaison of Japanese Society of Nephrology (JSN) in JSN-Vietnam Viet Duc Hospital of Sister Renal Center Program (Global Outreach Program in International Society of Nephrology)
  • Board member of International IgA nephropathy network
  • Councilor of the International Society of Nephrology
  • North East Asia regional Board Deputy Chair in International Society of Nephrology
  • Executive Councilor of the of the Japan Society of Adult Diseases
  • Executive Councilor of the of the Japanese Society of Nephrology
  • Executive Councilor of the Japanese Society for the Study of Hypertension in Pregnancy
  • Program Committee of the Executive Councilor of the International Society for the Study of Hypertension in Pregnancy 2020
  • ISN Regional Board Deputy Chair (North and East Asia Region)
  • ISN Regional Board Chair (North and East Asia Region)

Link